We are live on ! Find out more
UTHR icon

United Therapeutics
UTHR

461 hedge funds and large institutions have $9.45B invested in United Therapeutics in 2022 Q3 according to their latest regulatory filings, with 54 funds opening new positions, 170 increasing their positions, 160 reducing their positions, and 61 closing their positions.

New
Increased
Maintained
Reduced
Closed

104% more call options, than puts

Call options by funds: $104M | Put options by funds: $51M

2.74% more ownership

Funds ownership: 97.2% → 99.94% (+2.7%)

6% more repeat investments, than reductions

Existing positions increased: 170 | Existing positions reduced: 160

2% less funds holding

Funds holding: 472 → 461 (-11)

9% less capital invested

Capital invested by funds: $10.3B → $9.45B (-$878M)

11% less first-time investments, than exits

New positions opened: 54 | Existing positions closed: 61

25% less funds holding in top 10

Funds holding in top 10: 24 → 18 (-6)

Holders
461
Holders Change
-11
Holders Change %
-2.33%
% of All Funds
7.94%
Holding in Top 10
18
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-25%
% of All Funds
0.31%
New
54
Increased
170
Reduced
160
Closed
61
Calls
$104M
Puts
$51M
Net Calls
+$53.1M
Net Calls Change
+$3.64M

Top Buyers

1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$211M
2
Citadel Advisors
Citadel Advisors
Florida
+$124M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$63.7M
4
APM
Avidity Partners Management
Texas
+$54.7M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$36.6M

Top Sellers

1
Renaissance Technologies
Renaissance Technologies
New York
-$54.4M
2
PAMS
Pictet Asset Management (Switzerland)
Switzerland
-$41.7M
3
Bank of New York Mellon
Bank of New York Mellon
New York
-$39M
4
American Century Companies
American Century Companies
Missouri
-$36.1M
5
First Trust Advisors
First Trust Advisors
Illinois
-$35.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Royal Bank of Canada
151
Royal Bank of Canada
Ontario, Canada
$4.74M +$378K +1,690 +8%
GC
152
Guggenheim Capital
Illinois
$4.72M -$1.49M -6,668 -23%
Victory Capital Management
153
Victory Capital Management
Texas
$4.53M +$1.27M +5,693 +36%
BIP
154
Brandes Investment Partners
California
$4.08M -$357K -1,599 -8%
HWAM
155
Hennion & Walsh Asset Management
New Jersey
$4.07M -$283K -1,265 -6%
WG
156
Winton Group
United Kingdom
$3.96M +$183K +817 +5%
SBH
157
Segall Bryant & Hamill
Illinois
$3.87M +$218K +975 +6%
COPPSERS
158
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$3.78M +$25K +112 +0.6%
EVM
159
Eaton Vance Management
Massachusetts
$3.71M +$6.04K +27 +0.2%
IMRF
160
Illinois Municipal Retirement Fund
Illinois
$3.65M – – –
BNP Paribas Financial Markets
161
BNP Paribas Financial Markets
France
$3.62M +$249K +1,116 +7%
OA
162
Oak Associates
Ohio
$3.57M -$44.7K -200 -1%
FEG
163
Financial Enhancement Group
Indiana
$3.51M +$54.5K +244 +1%
KWILP
164
Kiwi Wealth Investments Limited Partnership
New Zealand
$3.45M – – –
PCIG
165
Partners Capital Investment Group
Massachusetts
$3.38M +$3.61M +16,129 New
Jane Street
166
Jane Street
New York
$3.33M +$3.23M +14,440 +976%
BC
167
Birchview Capital
Vermont
$3.14M – – –
IBT
168
International Biotechnology Trust
United Kingdom
$3.14M +$2.3M +10,287 +218%
Aviva
169
Aviva
United Kingdom
$3.12M -$476K -2,131 -13%
Teacher Retirement System of Texas
170
Teacher Retirement System of Texas
Texas
$3.1M +$1.69M +7,580 +105%
EAM
171
Erste Asset Management
Austria
$3.07M +$56.3K +252 +2%
CAM
172
Covenant Asset Management
New Jersey
$2.99M +$1.66M +7,408 +108%
Massachusetts Financial Services
173
Massachusetts Financial Services
Massachusetts
$2.97M -$434K -1,943 -12%
GTCM
174
Gyon Technologies Capital Management
New Jersey
$2.81M +$1.77M +7,908 +143%
OPERF
175
Oregon Public Employees Retirement Fund
Oregon
$2.78M +$17.7K +79 +0.6%
5 6
7
8 9

UTHR Hedge Fund Activity: Q3 2022 in Review

461 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in United Therapeutics (UTHR) for Q3 2022, worth a combined $9.45B — down 8.5% from $10.3B a quarter earlier.

Sellers outnumbered buyers: 61 funds closed out of UTHR and 54 opened new positions — a net loss of 7 holders — while 160 trimmed existing stakes and 170 added.

The largest buyer was Janus Henderson Group, adding an estimated $211M. The largest seller was Renaissance Technologies, cutting an estimated $54.4M.

  • 461 institutional investors held United Therapeutics (UTHR) as of Q3 2022, down from 472 in Q2 2022.
  • Funds reported $9.45B of United Therapeutics stock for Q3 2022, down 8.5% quarter-over-quarter.
  • 54 funds opened new United Therapeutics positions in Q3 2022 and 61 closed out, a net change of -7 holders.
  • The largest United Therapeutics buyer in Q3 2022 was Janus Henderson Group, an estimated $211M added.
  • The largest United Therapeutics seller in Q3 2022 was Renaissance Technologies, an estimated $54.4M sold.

Based on aggregated 13F filings for Q3 2022.